Asahi Kasei Pharma 1st Half Sales Show Significant Growth, Teribone May Exceed Peak Sales in 1st Year

November 6, 2012
According to non-consolidated half-year results for Asahi Kasei Pharma for April to September 2012 released on November 1, the company posted sales of 36.5 billion yen, up 18.4% in comparison to the same period a year earlier, on the steady...read more